It Ain't what you do, it's the way you do it: Five golden rules for transforming prostate-specific antigen screening

European Urology

Volumn 66, Issue 2, 2014, Pages 188-190

  Vickers, Andrew ^a   Carlsson, Sigrid ^a,b   Laudone, Vincent ^a   Lilja, Hans ^a,c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER MORTALITY; CANCER SCREENING; COMORBIDITY; DECISION MAKING; DIGITAL RECTAL EXAMINATION; GENERAL PRACTITIONER; GLEASON SCORE; HUMAN; LIFE EXPECTANCY; NOTE; PHENOTYPE; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; RISK REDUCTION; UROLOGIST; BIOPSY; BLOOD; EARLY CANCER DIAGNOSIS; HIGH VOLUME HOSPITAL; INFORMED CONSENT; MALE; PATHOLOGY; PROCEDURES; PROSTATE; PROSTATIC NEOPLASMS; RISK ASSESSMENT; STANDARDS;

BIOPSY; EARLY DETECTION OF CANCER; HOSPITALS, HIGH-VOLUME; HUMANS; INFORMED CONSENT; MALE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK ASSESSMENT;

EID: 84904069931     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2013.12.049     Document Type: Editorial

References (18)

1. S. Carlsson, A.J. Vickers, and M. Roobol et al. Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review J Clin Oncol 30 2012 2581 2584
2. R.J. Volk, S.K. Linder, and M.A. Kallen et al. Primary care physicians' use of an informed decision-making process for prostate cancer screening Ann Fam Med 11 2013 67 74
3. C.S. Sima, K.S. Panageas, and D. Schrag Cancer screening among patients with advanced cancer JAMA 304 2010 1584 1591
4. M.W. Drazer, D. Huo, M.A. Schonberg, A. Razmaria, and S.E. Eggener Population-based patterns and predictors of prostate-specific antigen screening among older men in the United States J Clin Oncol 29 2011 1736 1743
5. E.A. Heijnsdijk, E.M. Wever, and A. Auvinen et al. Quality-of-life effects of prostate-specific antigen screening N Engl J Med 367 2012 595 605
6. A.J. Vickers, A.M. Cronin, and T. Bjork et al. Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study BMJ 341 2010 c4521
7. P.J. van Leeuwen, D. Connolly, and T.L. Tammela et al. Balancing the harms and benefits of early detection of prostate cancer Cancer 116 2010 4857 4865
8. I.M. Thompson, D.K. Pauler, and P.J. Goodman et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter N Engl J Med 350 2004 2239 2246
9. J.A. Eastham, E. Riedel, and P.T. Scardino et al. Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuations JAMA 289 2003 2695 2700
10. R. Lee, A.R. Localio, K. Armstrong, S.B. Malkowicz, J.S. Schwartz Free PSA Study Group A meta-analysis of the performance characteristics of the free prostate-specific antigen test Urology 67 2006 762 768
11. C. Gosselaar, M.J. Roobol, S. Roemeling, and F.H. Schröder The role of the digital rectal examination in subsequent screening visits in the European randomized study of screening for prostate cancer (ERSPC) Rotterdam. Eur Urol 54 2008 581 588
12. A.J. Vickers, C. Till, C.M. Tangen, H. Lilja, and I.M. Thompson An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection J Natl Cancer Inst 103 2011 462 469
13. L. Klotz, L. Zhang, A. Lam, R. Nam, A. Mamedov, and A. Loblaw Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer J Clin Oncol 28 2010 126 131
14. A.C. Reese, P. Landis, M. Han, J.I. Epstein, and H.B. Carter Expanded criteria to identify men eligible for active surveillance of low risk prostate cancer at Johns Hopkins: a preliminary analysis J Urol 190 2013 2033 2038
15. T.J. Wilt, M.K. Brawer, and K.M. Jones et al. Radical prostatectomy versus observation for localized prostate cancer N Engl J Med 367 2012 203 213
16. J.A. Eastham Do high-volume hospitals and surgeons provide better care in urologic oncology? Urol Oncol 27 2009 417 421
17. A.J. Vickers, F.J. Bianco, and A.M. Serio et al. The surgical learning curve for prostate cancer control after radical prostatectomy J Natl Cancer Inst 99 2007 1171 1177
18. C.J. Savage, and A.J. Vickers Low annual caseloads of United States surgeons conducting radical prostatectomy J Urol 182 2009 2677 2679